Dana-Farber Cancer Institute
The purpose of the study is to evaluate if the smartphone app, I-STAMP (Integrated Smartphone Technology to Alleviate Malignant Pain), helps participants with cancer pain manage symptoms and keep track of medications.
The goal of this study is to develop and refine I-STAMP (Integrated Smartphone Technology to Alleviate Malignant Pain), an electronic health record-integrated mobile health (mHealth) application designed to support advanced cancer patients and care teams in pain management. The research study procedures include screening for eligibility, surveys, and interviews. It is expected that up to 73 participants will take part in this research study. Activities 1-3 are non-interventional and will be used to collect data for application development. Activity 4: This activity will be interventional and…
Inclusion Criteria for Participants (Activities 1a, 2a, 3a): * Age ≥ 21 years * Current or previous diagnosis of advanced cancer * Current or previous experience with cancer pain Exclusion Criteria for Participants (Activities 1a, 2a, 3a): * Inability to understand, speak, or read English * Any condition that would impede the patient's ability to complete study procedures such as visual impairment or significant cognitive impairment as determined by the participant's treating provider.
A patient-facing smartphone application that hosts participants' analgesic and laxative medications, provides pain-specific psychoeducation, collects patient reported outcomes, and provides feedback to participant symptoms.
Arctuva estimate
Verify or correct the compensation shown for this listing.